While IL-10 levels > 5.11 pg/mL were associated with an increased risk of anti-SS-A/Ro antibodies in SLE patients, no such relationship was identified with aCL (IgG and IgM) or aβ2GPI antibodies [111]. Here, ACLY is linked to systemic lupus erythematosus.